US 9487509
Heterocyclic compound
granted A61PA61P13/12A61P19/10
Quick answer
US patent 9487509 (Heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P13/12, A61P19/10, A61P21/00, A61P25/00